Managing Side Effects in Clinical Practice
NCT03475550 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31
Last updated 2022-12-15
Summary
This is a quality improvement health services study in the Division of Gastroenterology at Beth Israel Deaconess Medical Center (BIDMC).
Conditions
- Functional Gastrointestinal Disorders
Interventions
- OTHER
-
Standard of Care
The intervention involves clinician-provided information to patients receiving a new medication as part of their standard medical care. Intervention 1 includes more detailed information compared to Intervention 2.
Sponsors & Collaborators
-
Beth Israel Deaconess Medical Center
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-05-22
- Primary Completion
- 2019-12-30
- Completion
- 2020-09-30
Countries
- United States
Study Locations
More Related Trials
-
Patient Attributes for Optimal Treatment Outcome in Irritable Bowel Syndrome.
NCT01297556 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Trial Evaluating Diets for IBS
NCT05831306 ·Status: UNKNOWN ·Phase: NA
-
Irritable Bowel Syndrome and Food Sensitivity
NCT02186743 ·Status: COMPLETED ·Phase: NA
-
Exercise and Irritable Bowel Syndrome (IBS)
NCT05453084 ·Status: COMPLETED ·Phase: NA
-
The Effect of a Low FODMAP Diet in Irritable Bowel Syndrome Patients
NCT04373304 ·Status: UNKNOWN ·Phase: NA
-
Donor Versus Autologous Fecal Microbiota Transplantation for Irritable Bowel Syndrome
NCT04691544 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The FAIS-Trial: Faecal Microbiota Transplantation (FMT) in Adolescents With Refractory Irritable Bowel Syndrome (IBS)
NCT03074227 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate Fecal Microbiota Transplantation Engraftment in IBS
NCT02847481 ·Status: COMPLETED ·Phase: PHASE1
-
"Functional Bowel Disorder. Investigation in General Practice"
NCT01153295 ·Status: COMPLETED ·Phase: NA
-
Effects of Open-label vs Double-blind Treatment in IBS
NCT02802241 ·Status: COMPLETED ·Phase: NA
-
Intestinal Permeability and Intestinal Microbiota in Irritable Bowel Syndrome
NCT05379036 ·Status: UNKNOWN ·Phase: PHASE4
-
FMT in the Treatment of IBS
NCT03561519 ·Status: COMPLETED ·Phase: NA
-
Smartphone Training for Attention Regulation for IBS
NCT05083091 ·Status: COMPLETED ·Phase: NA
-
Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide
NCT00584298 ·Status: COMPLETED ·Phase: PHASE1
-
The Value of Bio-electrical Impedance Analysis in Irritable Bowel Syndrome
NCT05744258 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Evaluation of Fecal Microbiota Transplantation in Irritable Bowel Syndrome
NCT05740319 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Treatment Effect of Low FODMAP Diet in Treatment of IBS Patients
NCT05144204 ·Status: UNKNOWN ·Phase: NA
-
Integrative Approaches to Managing Irritable Bowel Syndrome (IBS)
NCT02436603 ·Status: COMPLETED ·Phase: NA
-
Faecal Microbiota Transplantation (FMT) in Patients With IBSmechanism(s) of Action
NCT04236843 ·Status: COMPLETED ·Phase: NA
-
Exclude or Expose in Irritable Bowel Syndrome: What Works for Whom and How?
NCT06940596 ·Status: RECRUITING ·Phase: NA
-
Fecal Microbiota Transplantation in Patients With Irritable Bowel Syndrome
NCT02092402 ·Status: COMPLETED ·Phase: NA
-
Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome
NCT02565550 ·Status: UNKNOWN ·Phase: PHASE4
-
Donor Selection for Faecal Microbiota Transplantation in Irritable Bowel Syndrome
NCT06171126 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Fecal Transplantation in Patients With IBS
NCT03333291 ·Status: COMPLETED ·Phase: NA
-
Multicenter Observational Prospective Study to Describe Irritable Bowel Syndrome in the Russian Federation
NCT03549143 ·Status: COMPLETED